BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23349346)

  • 1. Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study.
    Cimadevilla C; Cueff C; Hekimian G; Dehoux M; Lepage L; Iung B; Duval X; Huart V; Tubach F; Vahanian A; Messika-Zeitoun D
    Heart; 2013 Apr; 99(7):461-7. PubMed ID: 23349346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants and prognostic value of B-type natriuretic peptide in patients with aortic valve stenosis.
    Nguyen V; Cimadevilla C; Arangalage D; Dehoux M; Codogno I; Duval X; Tubiana S; Vahanian A; Messika-Zeitoun D
    Int J Cardiol; 2017 Mar; 230():371-377. PubMed ID: 28062138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis.
    Arangalage D; Nguyen V; Robert T; Melissopoulou M; Mathieu T; Estellat C; Codogno I; Huart V; Duval X; Cimadevilla C; Vahanian A; Dehoux M; Messika-Zeitoun D
    Heart; 2016 Jun; 102(11):862-8. PubMed ID: 26896466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
    Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
    Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
    Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
    Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.
    Bergler-Klein J; Klaar U; Heger M; Rosenhek R; Mundigler G; Gabriel H; Binder T; Pacher R; Maurer G; Baumgartner H
    Circulation; 2004 May; 109(19):2302-8. PubMed ID: 15117847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-dimensional strain for the assessment of left ventricular function in low flow-low gradient aortic stenosis, relationship to hemodynamics, and outcome: a substudy of the multicenter TOPAS study.
    Bartko PE; Heinze G; Graf S; Clavel MA; Khorsand A; Bergler-Klein J; Burwash IG; Dumesnil JG; Sénéchal M; Baumgartner H; Rosenhek R; Pibarot P; Mundigler G
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):268-76. PubMed ID: 23275349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Prognostic Value of High-Sensitivity Troponin T Added to N-Terminal Pro Brain Natriuretic Peptide Plasma Levels Before Valve Replacement for Severe Aortic Stenosis.
    Barbieri F; Senoner T; Adukauskaite A; Dobner S; Holfeld J; Semsroth S; Lambert T; Zweiker D; Theurl T; Rainer PP; Schmidt A; Feuchtner GM; Steinwender C; Hoppe UC; Hintringer F; Bauer A; Müller S; Grimm M; Pfeifer BE; Dichtl W
    Am J Cardiol; 2019 Dec; 124(12):1932-1939. PubMed ID: 31699359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation.
    Schewel D; Frerker C; Schewel J; Wohlmuth P; Meincke F; Thielsen T; Kreidel F; Kuck KH; Schäfer U
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):502-14. PubMed ID: 24259366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
    Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
    J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of tissue Doppler imaging and natriuretic peptides as prognostic marker in asymptomatic aortic stenosis.
    Gomez Perez M; Ble M; Cladellas M; Molina L; Vila J; Mas-Stachurska A; Higueras-Ortega L; Marti-Almor J
    Int J Cardiol; 2017 Feb; 228():890-894. PubMed ID: 27894060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
    Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
    Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.
    Lindman BR; Breyley JG; Schilling JD; Vatterott AM; Zajarias A; Maniar HS; Damiano RJ; Moon MR; Lawton JS; Gage BF; Sintek MA; Aquino A; Holley CL; Patel NM; Lawler C; Lasala JM; Novak E
    Heart; 2015 Sep; 101(17):1382-8. PubMed ID: 26037104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
    Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
    Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.